Detection of metastatic liver disease. Use of liver scans and biochemical liver tests

M. A. Tempero, R. J. Petersen, Rowen K Zetterman, H. M. Lemon, J. Gurney

Research output: Contribution to journalArticle

Abstract

The records of 94 patients with a known diagnosis of extrahepatic cancer having liver scan, biochemical liver tests (alkaline phosphatase, SGOT, lactic dehydrogenase, and bilirubin levels), and subsequent liver biopsy within a six-week period were reviewed. The sensitivity, specificity, and accuracy of the scan and biochemical tests in the detection of metastatic liver disease were calculated. The most sensitive single examination was the group of biochemical liver tests. Liver scans performed in the presence of normal biochemical test results were insensitive when compared with the liver scan alone or the liver scan in the presence of abnormal biochemical test results. The specificity and accuracy of all tests and test combinations were statistically equivalent. Screening for hepatic metastases in patients with cancer is best accomplished with the more sensitive and less expensive group of biochemical liver tests, reserving the liver scan for those patients with abnormal biochemical test results.

Original languageEnglish (US)
Pages (from-to)1329-1332
Number of pages4
JournalJournal of the American Medical Association
Volume248
Issue number11
DOIs
StatePublished - 1982

Fingerprint

Liver Diseases
Liver
Liver Neoplasms
Aspartate Aminotransferases
Bilirubin
Alkaline Phosphatase
Oxidoreductases
Milk
Neoplasm Metastasis
Biopsy
Sensitivity and Specificity
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Detection of metastatic liver disease. Use of liver scans and biochemical liver tests. / Tempero, M. A.; Petersen, R. J.; Zetterman, Rowen K; Lemon, H. M.; Gurney, J.

In: Journal of the American Medical Association, Vol. 248, No. 11, 1982, p. 1329-1332.

Research output: Contribution to journalArticle

Tempero, M. A. ; Petersen, R. J. ; Zetterman, Rowen K ; Lemon, H. M. ; Gurney, J. / Detection of metastatic liver disease. Use of liver scans and biochemical liver tests. In: Journal of the American Medical Association. 1982 ; Vol. 248, No. 11. pp. 1329-1332.
@article{353b9ae51cad49a1bf0ee6cf60e2b223,
title = "Detection of metastatic liver disease. Use of liver scans and biochemical liver tests",
abstract = "The records of 94 patients with a known diagnosis of extrahepatic cancer having liver scan, biochemical liver tests (alkaline phosphatase, SGOT, lactic dehydrogenase, and bilirubin levels), and subsequent liver biopsy within a six-week period were reviewed. The sensitivity, specificity, and accuracy of the scan and biochemical tests in the detection of metastatic liver disease were calculated. The most sensitive single examination was the group of biochemical liver tests. Liver scans performed in the presence of normal biochemical test results were insensitive when compared with the liver scan alone or the liver scan in the presence of abnormal biochemical test results. The specificity and accuracy of all tests and test combinations were statistically equivalent. Screening for hepatic metastases in patients with cancer is best accomplished with the more sensitive and less expensive group of biochemical liver tests, reserving the liver scan for those patients with abnormal biochemical test results.",
author = "Tempero, {M. A.} and Petersen, {R. J.} and Zetterman, {Rowen K} and Lemon, {H. M.} and J. Gurney",
year = "1982",
doi = "10.1001/jama.248.11.1329",
language = "English (US)",
volume = "248",
pages = "1329--1332",
journal = "JAMA - Journal of the American Medical Association",
issn = "0002-9955",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Detection of metastatic liver disease. Use of liver scans and biochemical liver tests

AU - Tempero, M. A.

AU - Petersen, R. J.

AU - Zetterman, Rowen K

AU - Lemon, H. M.

AU - Gurney, J.

PY - 1982

Y1 - 1982

N2 - The records of 94 patients with a known diagnosis of extrahepatic cancer having liver scan, biochemical liver tests (alkaline phosphatase, SGOT, lactic dehydrogenase, and bilirubin levels), and subsequent liver biopsy within a six-week period were reviewed. The sensitivity, specificity, and accuracy of the scan and biochemical tests in the detection of metastatic liver disease were calculated. The most sensitive single examination was the group of biochemical liver tests. Liver scans performed in the presence of normal biochemical test results were insensitive when compared with the liver scan alone or the liver scan in the presence of abnormal biochemical test results. The specificity and accuracy of all tests and test combinations were statistically equivalent. Screening for hepatic metastases in patients with cancer is best accomplished with the more sensitive and less expensive group of biochemical liver tests, reserving the liver scan for those patients with abnormal biochemical test results.

AB - The records of 94 patients with a known diagnosis of extrahepatic cancer having liver scan, biochemical liver tests (alkaline phosphatase, SGOT, lactic dehydrogenase, and bilirubin levels), and subsequent liver biopsy within a six-week period were reviewed. The sensitivity, specificity, and accuracy of the scan and biochemical tests in the detection of metastatic liver disease were calculated. The most sensitive single examination was the group of biochemical liver tests. Liver scans performed in the presence of normal biochemical test results were insensitive when compared with the liver scan alone or the liver scan in the presence of abnormal biochemical test results. The specificity and accuracy of all tests and test combinations were statistically equivalent. Screening for hepatic metastases in patients with cancer is best accomplished with the more sensitive and less expensive group of biochemical liver tests, reserving the liver scan for those patients with abnormal biochemical test results.

UR - http://www.scopus.com/inward/record.url?scp=0019941011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019941011&partnerID=8YFLogxK

U2 - 10.1001/jama.248.11.1329

DO - 10.1001/jama.248.11.1329

M3 - Article

C2 - 7109154

VL - 248

SP - 1329

EP - 1332

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0002-9955

IS - 11

ER -